Equities

Vineet Laboratories Ltd

VINEETLAB:NSI

Vineet Laboratories Ltd

Actions
Health CarePharmaceuticals and Biotechnology
  • Price (INR)59.14
  • Today's Change0.17 / 0.29%
  • Shares traded8.67k
  • 1 Year change+15.96%
  • Beta--
Data delayed at least 15 minutes, as of Sep 20 2024 11:14 BST.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Financials data is unavailable for this security.

Balance sheet Back to Overview

In millions of INR
(except for per share items)
Fiscal data as of Mar 31 2024202420232022
ASSETS
Cash And Short Term Investments4.999.76181
Total Receivables, Net316352362
Total Inventory494462435
Prepaid expenses------
Other current assets, total675148
Total current assets8828751,027
Property, plant & equipment, net269266214
Goodwill, net------
Intangibles, net------
Long term investments1.821.341.36
Note receivable - long term141389
Other long term assets1.683.061.80
Total assets1,1691,1581,333
LIABILITIES
Accounts payable323349601
Accrued expenses------
Notes payable/short-term debt3912520
Current portion long-term debt/capital leases1310248
Other current liabilities, total3313499
Total current liabilities760745948
Total long term debt394817
Total debt443311265
Deferred income tax152118
Minority interest------
Other liabilities, total8.067.5418
Total liabilities8218221,001
SHAREHOLDERS EQUITY
Common stock929292
Additional paid-in capital------
Retained earnings (accumulated deficit)255245240
Treasury stock - common------
Unrealized gain (loss)------
Other equity, total------
Total equity347337332
Total liabilities & shareholders' equity1,1691,1581,333
Total common shares outstanding9.229.229.22
Treasury shares - common primary issue000
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.